2.2.0.25 true Sheet 0010 - Statement - Condensed Consolidated Balance Sheets Condensed Consolidated Balance Sheets http://www.vrtx.com/role/BalanceSheet false R1.xml false Sheet 0015 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Condensed Consolidated Balance Sheets (Parenthetical) http://www.vrtx.com/role/BalanceSheetParenthetical false R2.xml false Sheet 0020 - Statement - Condensed Consolidated Statements of Operations Condensed Consolidated Statements of Operations http://www.vrtx.com/role/StatementOfIncome false R3.xml false Sheet 0030 - Statement - Condensed Consolidated Statements of Cash Flows Condensed Consolidated Statements of Cash Flows http://www.vrtx.com/role/CashFlows false R4.xml false Sheet 1010 - Disclosure - Basis of Presentation Basis of Presentation http://www.vrtx.com/role/DisclosureBasisOfPresentation false R5.xml false Sheet 1020 - Disclosure - Accounting Policies Accounting Policies http://www.vrtx.com/role/DisclosureAccountingPolicies false R6.xml false Sheet 1030 - Disclosure - Stock-based Compensation Expense Stock-based Compensation Expense http://www.vrtx.com/role/DisclosureStockBasedCompensationExpense false R7.xml false Sheet 1040 - Disclosure - Marketable Securities Marketable Securities http://www.vrtx.com/role/DisclosureMarketableSecurities false R8.xml false Sheet 1050 - Disclosure - Fair Value of Financial Instruments Fair Value of Financial Instruments http://www.vrtx.com/role/DisclosureFairValueOfFinancialInstruments false R9.xml false Sheet 1060 - Disclosure - Comprehensive Loss Comprehensive Loss http://www.vrtx.com/role/DisclosureComprehensiveLoss false R10.xml false Sheet 1070 - Disclosure - Income Taxes Income Taxes http://www.vrtx.com/role/DisclosureIncomeTaxes false R11.xml false Sheet 1080 - Disclosure - Inventories Inventories http://www.vrtx.com/role/DisclosureInventories false R12.xml false Sheet 1090 - Disclosure - Restructuring Expense Restructuring Expense http://www.vrtx.com/role/DisclosureRestructuringExpense false R13.xml false Notes 1100 - Disclosure - Convertible Senior Subordinated Notes due 2015 Convertible Senior Subordinated Notes due 2015 http://www.vrtx.com/role/DisclosureConvertibleSeniorSubordinatedNotesDue2015 false R14.xml false Sheet 1110 - Disclosure - Collaborative Arrangements Collaborative Arrangements http://www.vrtx.com/role/DisclosureCollaborativeArrangements false R15.xml false Sheet 1120 - Disclosure - Acquisition of ViroChem Pharma Inc. Acquisition of ViroChem Pharma Inc. http://www.vrtx.com/role/DisclosureAcquisitionOfBusiness false R16.xml false Sheet 1130 - Disclosure - September 2009 Financial Transactions September 2009 Financial Transactions http://www.vrtx.com/role/DisclosureSeptember2009FinancialTransactions false R17.xml false Sheet 1140 - Disclosure - Sale of HIV Protease Inhibitor Royalty Stream Sale of HIV Protease Inhibitor Royalty Stream http://www.vrtx.com/role/DisclosureSaleOfHIVProteaseInhibitorRoyaltyStream false R18.xml false Sheet 1150 - Disclosure - Credit Agreement Credit Agreement http://www.vrtx.com/role/DisclosureCreditAgreement false R19.xml false Sheet 1160 - Disclosure - Guarantees Guarantees http://www.vrtx.com/role/DisclosureGuarantees false R20.xml false Sheet 1170 - Disclosure - Contingencies Contingencies http://www.vrtx.com/role/DisclosureContingencies false R21.xml false Sheet 1180 - Disclosure - Subsequent Event Subsequent Event http://www.vrtx.com/role/DisclosureSubsequentEvent false R22.xml false Sheet 2020 - Disclosure - Accounting Policies (Policies) Accounting Policies (Policies) http://www.vrtx.com/role/DisclosureAccountingPoliciesPolicies false R23.xml false Sheet 3020 - Disclosure - Accounting Policies (Tables) Accounting Policies (Tables) http://www.vrtx.com/role/DisclosureAccountingPoliciesTables false R24.xml false Sheet 3030 - Disclosure - Stock-based Compensation Expense (Tables) Stock-based Compensation Expense (Tables) http://www.vrtx.com/role/DisclosureStockBasedCompensationExpensesTables false R25.xml false Sheet 3040 - Disclosure - Marketable Securities (Tables) Marketable Securities (Tables) http://www.vrtx.com/role/DisclosureMarketableSecuritiesTables false R26.xml false Sheet 3050 - Disclosure - Fair Value of Financial Instruments (Tables) Fair Value of Financial Instruments (Tables) http://www.vrtx.com/role/DisclosureFairValueOfFinancialInstrumentsTables false R27.xml false Sheet 3060 - Disclosure - Comprehensive Loss (Tables) Comprehensive Loss (Tables) http://www.vrtx.com/role/DisclosureComprehensiveLossTables false R28.xml false Sheet 3080 - Disclosure - Inventories (Tables) Inventories (Tables) http://www.vrtx.com/role/DisclosureInventoriesTables false R29.xml false Sheet 3090 - Disclosure - Restructuring Expense (Tables) Restructuring Expense (Tables) http://www.vrtx.com/role/DisclosureRestructuringExpenseTables false R30.xml false Sheet 3110 - Disclosure - Collaborative Arrangements (Tables) Collaborative Arrangements (Tables) http://www.vrtx.com/role/DisclosureCollaborativeArrangementsTables false R31.xml false Sheet 3130 - Disclosure - September 2009 Financial Transactions (Tables) September 2009 Financial Transactions (Tables) http://www.vrtx.com/role/DisclosureSeptember2009FinancialTransactionsTables false R32.xml false Sheet 4020 - Disclosure - Accounting Policies (Details) Accounting Policies (Details) http://www.vrtx.com/role/DisclosureAccountingPoliciesDetails false R33.xml false Sheet 4021 - Disclosure - Accounting Policies (Details 2) Accounting Policies (Details 2) http://www.vrtx.com/role/DisclosureAccountingPoliciesDetails2 false R34.xml false Sheet 4030 - Disclosure - Stock-based Compensation Expense (Details) Stock-based Compensation Expense (Details) http://www.vrtx.com/role/DisclosureStockBasedCompensationExpensesDetails false R35.xml false Sheet 4031 - Disclosure - Stock-based Compensation Expense (Details 2) Stock-based Compensation Expense (Details 2) http://www.vrtx.com/role/DisclosureStockBasedCompensationExpenseDetails2 false R36.xml false Sheet 4040 - Disclosure - Marketable Securities (Details) Marketable Securities (Details) http://www.vrtx.com/role/DisclosureMarketableSecuritiesDetails false R37.xml false Sheet 4041 - Disclosure - Marketable Securities (Details 2) Marketable Securities (Details 2) http://www.vrtx.com/role/DisclosureMarketableSecuritiesDetails2 false R38.xml false Sheet 4050 - Disclosure - Fair Value of Financial Instruments (Details) Fair Value of Financial Instruments (Details) http://www.vrtx.com/role/DisclosureFairValueOfFinancialInstrumentsDetails false R39.xml false Sheet 4051 - Disclosure - Fair Value of Financial Instruments (Details 2) Fair Value of Financial Instruments (Details 2) http://www.vrtx.com/role/DisclosureFairValueOfFinancialInstrumentsDetails2 false R40.xml false Sheet 4052 - Disclosure - Fair Value of Financial Instruments (Details 3) Fair Value of Financial Instruments (Details 3) http://www.vrtx.com/role/DisclosureFairValueOfFinancialInstrumentsDetails3 false R41.xml false Sheet 4060 - Disclosure - Comprehensive Loss (Details) Comprehensive Loss (Details) http://www.vrtx.com/role/DisclosureComprehensiveLossDetails false R42.xml false Sheet 4080 - Disclosure - Inventories (Details) Inventories (Details) http://www.vrtx.com/role/DisclosureInventoriesDetails false R43.xml false Sheet 4090 - Disclosure - Restructuring Expense (Details) Restructuring Expense (Details) http://www.vrtx.com/role/DisclosureRestructuringExpenseDetails false R44.xml false Sheet 4091 - Disclosure - Restructuring Expense (Details 2) Restructuring Expense (Details 2) http://www.vrtx.com/role/DisclosureRestructuringExpenseDetails2 false R45.xml false Notes 4100 - Disclosure - Convertible Senior Subordinated Notes due 2015 (Details) Convertible Senior Subordinated Notes due 2015 (Details) http://www.vrtx.com/role/DisclosureConvertibleSeniorSubordinatedNotesDue2015Details false R46.xml false Sheet 4110 - Disclosure - Collaborative Arrangements (Details) Collaborative Arrangements (Details) http://www.vrtx.com/role/DisclosureCollaborativeArrangementsDetails false R47.xml false Sheet 4120 - Disclosure - Acquisition of ViroChem Pharma Inc. (Details) Acquisition of ViroChem Pharma Inc. (Details) http://www.vrtx.com/role/DisclosureAcquisitionOfViroChemPharmaIncDetails false R48.xml false Sheet 4130 - Disclosure - September 2009 Financial Transactions (Details) September 2009 Financial Transactions (Details) http://www.vrtx.com/role/DisclosureSeptember2009FinancialTransactionsDetails false R49.xml false Sheet 4140 - Disclosure - Sale of HIV Protease Inhibitor Royalty Stream (Details) Sale of HIV Protease Inhibitor Royalty Stream (Details) http://www.vrtx.com/role/DisclosureSaleOfHIVProteaseInhibitorRoyaltyStreamDetails false R50.xml false Sheet 4150 - Disclosure - Credit Agreement (Details) Credit Agreement (Details) http://www.vrtx.com/role/DisclosureCreditAgreementDetails false R51.xml false Sheet 4170 - Disclosure - Subsequent Event (Details) Subsequent Event (Details) http://www.vrtx.com/role/DisclosureSubsequentEventDetails false R52.xml false Sheet 9999 - Document - Document and Entity Information Document and Entity Information http://www.vrtx.com/role/DocumentAndEntityInformation false R53.xml false Book All Reports All Reports false 1 96 32 0 4 262 false false I2011Q1_ExercisePriceRangeFromDollars50.01ToDollars50.51Member 2 D2009Q3_M03_ViroChemPharmaMember 2 D2010_ConvertibleSeniorSubordinatedNotes3.35PercentDue2015Member 1 I2011Q1_USGovernmentSponsoredEnterprisesDebtSecuritiesMember 6 D2011Q1_StockOptionsMember 2 D2011Q1_EmployeeStockOptionMember 2 D2010Q1_EmployeeStockPurchasePlanMember 1 I2011Q1_USTreasurySecuritiesMember 3 D2006Q2_M06_JanssenCollaborativeAgreementMember 4 I2011Q1_USGovernmentSponsoredEnterprisesDebtSecuritiesCashEquivalentMember 3 D2011Q1 117 D2010Q1_JanssenCollaborativeAgreementMember 5 D2009Q3_M09 5 I2010_USGovernmentSponsoredEnterprisesDebtSecuritiesMember 6 I2011Q1_CashAndCashEquivalentsMember 4 I2011Q1_ExercisePriceRangeFromDollars40.01ToDollars50.00Member 2 D2011Q1_ExercisePriceRangeFromDollars30.01ToDollars40.00Member 5 I2011Q1_ViroChemPharmaMember_VX222Member 1 I2011Q1_EmployeeRestrictedStockOptionMember 1 D2010Q1_RestrictedStockMember 1 I2011Q1_ExercisePriceRangeFromDollars8.68ToDollars20.00Member 2 I2010_ViroChemPharmaMember 1 I2010 53 D2010_USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2 D2011Q1_ExercisePriceRangeFromDollars8.68ToDollars20.00Member 5 I2011Q1_CashAndMoneyMarketFundsMember 2 D2011Q1_RestrictedStockMember 1 D2011Q1_ExercisePriceRangeFromDollars40.01ToDollars50.00Member 5 I2011Q1_EmployeeStockOptionMember 1 D2006_FacilityClosingMember 1 D2010Q1_ShareBasedCompensationInResearchAndDevelopmentExpenseMember 1 I2011Q1_USTreasurySecuritiesCashEquivalentMember 3 D2010Q1_ShareBasedCompensationInSalesGeneralAndAdministrativeExpenseMember 1 D2010Q1 56 I2010_USGovernmentSponsoredEnterprisesDebtSecuritiesCashEquivalentMember 4 D2010Q1_StockOptionsMember 2 I2009Q1_M0312_ViroChemPharmaMember 2 D2010_USTreasurySecuritiesMember 2 I2010Q1 3 I2011Q1_MitsubishiTanabeCollaborativeAgreementtMember 1 I2011Q1_ViroChemPharmaMember 1 I2010_CashAndMoneyMarketFundsMember 2 I2011Q1 58 I2011Q1_JanssenCollaborativeAgreementMember 1 D2011Q1_M02 2 D2011Q1_ConvertibleDebtSecuritiesMember 2 D2010Q3_M09_ConvertibleSeniorSubordinatedNotes3.35PercentDue2015Member 7 I2011Q1_EmployeeStockPurchasePlanMember 1 D2006Q3_M07_JanssenCollaborativeAgreementMember 1 D2010_M09_ConvertibleSeniorSubordinatedNotes3.35PercentDue2015Member 1 I2011Q2_M0428 1 D2011Q1_EmployeeStockPurchasePlanMember 2 D2011Q1_NewContractMember 5 D2003Q2_M06_FacilityClosingMember 1 D2011Q1_EmployeeRestrictedStockOptionMember 2 I2003_FacilityClosingMember 1 I2010Q3_M09 1 I2010Q3_M0928_ConvertibleSeniorSubordinatedNotes3.35PercentDue2015Member 5 D2011Q1_ExercisePriceRangeFromDollars50.01ToDollars50.51Member 5 I2010_AvailableforsaleSecuritiesMember 4 I2011Q1_ExercisePriceRangeFromDollars20.01ToDollars30.00Member 2 D2011Q1_ConvertibleSeniorSubordinatedNotes3.35PercentDue2015Member 1 D2010Q1_EmployeeRestrictedStockOptionMember 1 I2011Q1_ConvertibleSeniorSubordinatedNotes3.35PercentDue2015Member 3 D2003Q1_M01_FacilityClosingMember 1 I2011Q1_M0107_BankOfAmericaMember 4 D2011Q1_ShareBasedCompensationInSalesGeneralAndAdministrativeExpenseMember 1 I2009 2 I2010Q3_M09_ConvertibleSeniorSubordinatedNotes3.35PercentDue2015Member 1 D2011Q1_ShareBasedCompensationInResearchAndDevelopmentExpenseMember 1 I2011Q1_ExercisePriceRangeFromDollars30.01ToDollars40.00Member 2 D2011Q1_ExercisePriceRangeFromDollars20.01ToDollars30.00Member 5 I2010_ViroChemPharmaMember_VX759Member 1 D2011Q1_M01_BankOfAmericaMember 2 D2011Q1_JanssenCollaborativeAgreementMember 11 I2010_ViroChemPharmaMember_VX222Member 1 D2011Q1_MitsubishiTanabeCollaborativeAgreementtMember 4 D2008 1 D2010Q1_EmployeeStockOptionMember 1 D2007_JanssenCollaborativeAgreementMember 1 D2011Q1_USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2 D2010Q1_MitsubishiTanabeCollaborativeAgreementtMember 2 I2011Q1_ConvertibleSeniorSubordinatedNotes3.35PercentDue2015Member2 1 I2009Q3_M09 1 D2009Q3_JanssenCollaborativeAgreementMember 1 D2009Q3_MitsubishiTanabeCollaborativeAgreementtMember 4 I2010_USTreasurySecuritiesMember 6 I2011Q1_AvailableforsaleSecuritiesMember 4 I2011Q1_ViroChemPharmaMember_VX759Member 1 I2010_USTreasurySecuritiesCashEquivalentMember 2 I2011Q1_FairValueInputsLevel3Member 3 I2011Q1_FairValueInputsLevel1Member 7 I2010_CashAndCashEquivalentsMember 4 D2009Q3_M09_JanssenCollaborativeAgreementMember 2 I2011Q1_EstimateOfFairValueFairValueDisclosureMember 10 D2010 3 true true